Brittle bone breakthrough? drug may restore hearing
NCT ID NCT04152551
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether bisphosphonates, drugs commonly used to strengthen bones, can also treat hearing loss in people with Osteogenesis Imperfecta (OI) type I. Researchers will enroll 100 adults and children with OI, giving some the drug and comparing their hearing over time. The goal is to see if this treatment can slow or improve hearing loss that often starts early in life for people with OI.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital for Special Surgery
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dental scans and AI could spot rare bone diseases faster
- Wearable sensors shed light on movement in brittle bone disease
- BONeMOVE: exercise boosts stamina in kids with brittle bones
- New shot aims to toughen fragile bones in rare disease
- Gentle exercise with cuffs may strengthen bones and muscles in brittle bone disease
- Massive database aims to unlock secrets of facial birth defects